Science Foundation Ireland (SFI) and The Health Research Board (HRB) are collaborating to support Irish researchers to engage in transnational collaborative research in the field of personalised medicine as a part of the European Partnership for Personalised Medicine (EP PerMed) 2024 Call for PMTargets.

The vision of EP PerMed is to improve health outcomes within sustainable healthcare systems through research, development, innovation and implementation of personalised medicine approaches for the benefit of patients, citizens and society. 

EP PerMed in building on over 15 years of EU-funded consortia will continue the activities of ERA PerMed in funding transnational innovation and research projects and work closely with ICPerMed for overarching strategic activities.  

The overall objectives of the JTC2024 are to

  • Support research projects aiming at identifying or validating targets for personalised medicine approaches in combination with development of companion biomarkers or other markers to allow for monitoring of treatment outcomes and patient stratification;
  • Encourage and enable interdisciplinary collaborations by combining pre-clinical and clinical research in translational projects, and multi-actor research by engaging a range of other relevant disciplines such as bioinformatics/health informatics/data research, ELSA research, implementation research or health economics research connected to the proposed research topic, including end-user perspective analysis to empower the implementation of PM; and
  • Encourage cross-sectorial collaborations, by including the private sector (e.g. SMEs, small and medium-sized enterprises), industry, as well as regulatory/HTA agencies and patient organisations.

Expected timeline of the call

02 January, 2024 Publication of the call
12 January, 2024 Opening of the pre-proposals submission system
15-18 January (TBD) JTC2024 information day
05 March, 2024 (17:00, CET) Deadline for pre-porposal submission
Expected around 20 May, 2024 Communication of the results of the pre-proposal assessment and invitation to the full-proposal stage
20 June, 2024 (17:00, CEST) Deadline for full-proposal submission
Mid/end of August 2024 Rebuttal stage
Expected for October 2024 Communication of the funding decisions to the applicants
End of 2024, beginning of 2025 Expected project start (according to regional/national funding regulations)

Further details on funding and about eligibility criteria and rules regarding consortium composition will be available soon. For further information on the upcoming call, please visit the EP PerMed website.